# Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

> **NCT07702461** · — · RECRUITING · sponsor: **Ohio State University** · enrollment: 300 (estimated)

## Conditions studied

- Obesity & Overweight
- Diabetes (DM)

## Interventions

- **DRUG:** Glucagon-Like Peptide-1 Agonist (GLP-1)

## Key facts

- **NCT ID:** NCT07702461
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-12
- **Primary completion:** 2026-10
- **Final completion:** 2027-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07702461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07702461, "Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07702461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*